The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting

Juju Zhou1, Xiaoqian Zhu1, Weihan Chen1

  • 1Cancer Hospital of Shantou University Medical College, Shantou, China.

Aging and Disease
|June 3, 2026
PubMed

Insights

Dickkopf (DKK) proteins regulate Wnt signaling and are crucial for development. Recent research highlights their roles in non-oncological diseases, suggesting potential as biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The Dickkopf (DKK) family (DKK1-4) are secreted glycoproteins.
  • DKK proteins antagonize the Wnt/β-catenin signaling pathway.
  • This pathway is vital for cellular proliferation, differentiation, development, and tissue homeostasis.

Purpose of the Study:

  • To review recent research (past three years) on DKK protein roles in non-oncological diseases.
  • To examine the potential of DKK proteins as diagnostic biomarkers.
  • To explore DKK proteins as therapeutic targets for non-oncological conditions.

Main Methods:

  • Systematic literature review.
  • Analysis of recent research findings (past three years).
  • Synthesis of data on DKK protein involvement in various diseases.

Main Results:

  • DKK protein dysregulation is linked to cancers.
  • DKK family members are implicated in osteoporosis, arthritis, chronic kidney disease (CKD), myocardial injury, Alzheimer's disease (AD), and alopecia.
  • DKK proteins show potential as biomarkers and therapeutic targets.

Conclusions:

  • DKK proteins play significant roles in diverse non-oncological diseases.
  • Further research into DKK proteins could lead to novel diagnostic and therapeutic strategies.
  • Addressing challenges in DKK research is key for clinical applications.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...